BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Repáraz D, Aparicio B, Llopiz D, Hervás-Stubbs S, Sarobe P. Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens? Int J Mol Sci 2022;23:2022. [PMID: 35216137 DOI: 10.3390/ijms23042022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Barsch M, Salié H, Mesesan A, Bengsch B. T cells in the heterogeneous tumour immune microenvironment of hepatocellular carcinoma: Implications for immune checkpoint inhibitor therapy. Liver Cancer International 2023. [DOI: 10.1002/lci2.72] [Reference Citation Analysis]
2 Ozer M, Goksu SY, Akagunduz B, George A, Sahin I. Adoptive Cell Therapy in Hepatocellular Carcinoma: A Review of Clinical Trials. Cancers 2023;15:1808. [DOI: 10.3390/cancers15061808] [Reference Citation Analysis]
3 Yang YQ, Wen ZY, Liu XY, Ma ZH, Liu YE, Cao XY, Hou L, Xie H. Current status and prospect of treatments for recurrent hepatocellular carcinoma. World J Hepatol 2023;15:129-50. [PMID: 36926237 DOI: 10.4254/wjh.v15.i2.129] [Reference Citation Analysis]
4 Ruff SM, Shannon AH, Pawlik TM. Advances in Targeted Immunotherapy for Hepatobiliary Cancers. Int J Mol Sci 2022;23. [PMID: 36430440 DOI: 10.3390/ijms232213961] [Reference Citation Analysis]
5 Sarantis P, Trifylli E, Koustas E, Papavassiliou KA, Karamouzis MV, Papavassiliou AG. Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors. IJMS 2022;23:13612. [DOI: 10.3390/ijms232113612] [Reference Citation Analysis]
6 Ruff SM, Shannon AH, Beane JD, Pawlik TM. Highlighting novel targets in immunotherapy for liver cancer. Expert Rev Gastroenterol Hepatol 2022;16:1029-41. [PMID: 36404729 DOI: 10.1080/17474124.2022.2150841] [Reference Citation Analysis]
7 Cassese G, Han HS, Lee B, Lee HW, Cho JY, Panaro F, Troisi RI. Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease. World J Hepatol 2022;14:1862-74. [PMID: 36340753 DOI: 10.4254/wjh.v14.i10.1862] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]